FDA warns against 5 cosmetics products » Manila Bulletin News

Manila Bulletin Philippines

Breaking News from the Nation's leading newspaper

Tempo

Online Newspaper

Showbiz and Celebrity News

Sports News

World News
News Asia

FDA warns against 5 cosmetics products

Published

By Analou De Vera

The Food and Drug Administration (FDA) has warned the public against five “unnotified” cosmetic products being sold in the market.

Food and Drug Administration  (FDA official Facebook page / MANILA BULLETIN)

Food and Drug Administration (FDA Official Facebook page / MANILA BULLETIN)

In its advisory, the FDA said the “unnotified” cosmetic products were Kaxier BB Cream White Crystalin Perfect Concealer (04); Ivy Beauty Light Silk Blusher (4); Jialiqi 24 Hours Waterproof Lasting Eyeliner (black); Jialiqi Precision Eyeliner; and Ushas Eyeshadow Palette (3).

“Unnotified” products, according to the FDA have not gone through the evaluation process of the agency and have not been issued the proper authorization in the form Certificate of Product Notification.

“Pursuant to Republic Act No. 9711, otherwise known as the ‘Food and Drug Administration Act of 2009,’ the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising or sponsorship of health products without the proper authorization from FDA is prohibited,” the FDA said.

“The agency cannot assure their quality and safety. The use of such violative products may pose health risks to consumers,” the agency said.

“In light of the foregoing, the public is advised not to purchase the aforementioned violative products,” it added.

The FDA warned concerned establishments not to distribute the said products “until they have been issued the appropriate authorization.”

The agency advised the public to always check if a cosmetic product is “notified” with them by accessing the FDA website.

The public is also encouraged to report any sale or distribution of unnotified cosmetic products through the agency’s online reporting facility, eReport, which can be accessed at www.fda.gov.ph/ereport.

Related Posts